Galanis, Evanthia
Mayo Clinic
6 papers on CoChatORCID 0000-0001-8014-786X
Most cited papers
- Verified
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology
Glioma Diagnosis and TreatmentOvarian cancer diagnosis and treatment
Cited by 1,168
- Verified · note
Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
Sarkaria, J. N., Hu, L. S., Parney, I. F., Pafundi, D. H., Brinkmann, D. H., Laack, N. N., Giannini, C., Burns, T. C., Kizilbash, S. H., Laramy, J. K., et al. (2018) · Neuro-Oncology
Barrier Structure and Function StudiesGlioma Diagnosis and Treatment
Cited by 746
- Verified
BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas
Brastianos, P. K., Twohy, E., Geyer, S., Gerstner, E. R., Kaufmann, T. J., Tabrizi, S., Kabat, B., Thierauf, J., Ruff, M. W., Bota, D. A., et al. (2023) · New England Journal of Medicine
Pituitary Gland Disorders and TreatmentsNeuroendocrine Tumor Research Advances
Cited by 146
- Verified
CODEL: Phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design
Jaeckle, K. A., Ballman, K. V., van den Bent, M., Giannini, C., Galanis, E., Brown, P. D., Jenkins, R. B., Cairncross, J. G., Wick, W., Weller, M., et al. (2021) · Neuro-Oncology
Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy
Cited by 119
- Verified
Current Concepts in the Evaluation and Treatment of Osteosarcoma
Papagelopoulos, P. J., Galanis, E. C., Vlastou, C., Nikiforidis, P. A., Vlamis, J. A., Boscainos, P. J., Fragiadakis, E. G., Stamos, K. G., Pantazopoulos, T., & Sim, F. H. (2000) · Orthopedics
Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments
Cited by 42
- Verified
A phase (Ph) 0/Ia study of brigimadlin concentration in brain tissue and a non-randomized, open-label, dose escalation study of brigimadlin in combination with radiotherapy (RT) in patients (pts) with newly diagnosed glioblastoma (GBM)
Sarkaria, J. N., Mrugala, M. M., Jaeckle, K. A., Burns, T. C., Vaubel, R. A., Parney, I. F., Chaichana, K., Clement, P. M., Martinez-Garcia, M., Sepulveda Sanchez, J. M., et al. (2024) · Journal of Clinical Oncology
Glioma Diagnosis and TreatmentCancer-related Molecular Pathways
Cited by 3
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free